1 |
Kim KS, Kim S, Han SA, et al. Contralateral prophylactic mastectomy and prophylactic salphingo-oophorectomy in a BRCA1-Positive breast cancer patient: a case report. J Breast Cancer 2008;11:218-22.
DOI
|
2 |
Kim KS, Kim SW, Lee MH, et al. Practice patterns of surgeons for the management of hereditary breast cancer in Korea. J Breast Cancer 2008;11:95-101.
DOI
|
3 |
Chenevix-Trench G, Milne RL, Antoniou AC, et al. An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Breast Cancer Res 2007;9:104.
DOI
|
4 |
Parmigiani G, Berry D, Aguilar O. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 1998;62:145-58.
DOI
|
5 |
Silva E. Genetic counseling and clinical management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations: perspective of a surgical oncologist. Fam Cancer 2008;7:91-5.
DOI
|
6 |
Lostumbo L, Carbine NE, Wallace J. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev 2010;(11):CD002748.
|
7 |
Korean Breast Cancer Society. Breast cancer facts & figures, 2013. Seoul: Korean Breast Cancer Society; 2013.
|
8 |
Claus EB, Schildkraut JM, Thompson WD, et al. The genetic attributable risk of breast and ovarian cancer. Cancer 1996; 77:2318-24.
DOI
|
9 |
Rebbeck TR, Lynch HT, Neuhausen SL, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 2002;346:1616-22.
DOI
|
10 |
Hartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 1999;340:77-84.
DOI
|
11 |
See HT, Cheung YB, Yong F, et al. Acceptance of prophylactic surgery and chemoprevention of cancer in Singapore: a survey. Ann Acad Med Singapore 2005;34:238-42.
|
12 |
Stefanek ME, Helzlsouer KJ, Wilcox PM, et al. Predictors of and satisfaction with bilateral prophylactic mastectomy. Prev Med 1995;24:412-9.
DOI
|
13 |
Scheuer L, Kauff N, Robson M, et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 2002;20:1260-8.
DOI
|
14 |
Son BH, Ahn SH, Lee MH, et al. Hereditary breast cancer in Korea: a review of the literature. J Breast Cancer 2008;11: 1-9.
DOI
|
15 |
Schrag D, Kuntz KM, Garber JE, et al. Decision analysis: effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med 1997;336:1465-71.
DOI
|
16 |
Schrag D, Kuntz KM, Garber JE, et al. Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations. JAMA 2000;283:617-24.
DOI
|